SCHEMBL474835

SCHEMBL474835

NNC(=O)c1cc2ccccc2[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 1.00
ALDH1A1 P00352 2/20 1.00
GAA P10253 1/20 1.00
MAPK1 P28482 1/20 1.00
HSD17B10 Q99714 2/20 0.66
NPC1 O15118 1/20 0.66
LMNA P02545 1/20 0.66
RAB9A P51151 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66
FLT3 P36888 1/20 0.65
MAPT P10636 1/20 0.62
DAO P14920 1/20 0.62
HPGD P15428 1/20 0.62
SRD5A2 P31213 1/20 0.62
DRD2 P14416 2/20 0.61
DRD3 P35462 1/20 0.61
AKR1C3 P42330 1/20 0.60
HTR2C P28335 1/20 0.60
HDAC3 O15379 1/20 0.58
HDAC4 P56524 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29580477 1.00 KDM4E (1.00) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL5279027 0.85 KDM4E (0.74) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL721792 0.84 KDM4E (0.72) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL31081137 0.84 KDM4E (0.72) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL5164287 0.83 KDM4E (0.71) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL1204954 0.82 KDM4E (0.69) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL1204956 0.82 KDM4E (0.69) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL23331084 0.82 FLT3 (0.70) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL29354546 0.82 KDM4E (0.70) KDM4EALDH1A1GAAMAPK1HSD17B10
SCHEMBL1254745 0.82 KDM4E (0.70) KDM4EALDH1A1GAAMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059901-A 1,3, 4-Oxadiazole compound and preparation method and application thereof 成都大学 2026-05-19 CN claimed
CN-122036615-A Indazole hydrazide compound and preparation method and application thereof 南京农业大学 2026-05-15 CN claimed
CN-117603188-A Indole and quinoline skeleton-containing compound and application thereof 苏州卫生职业技术学院 2024-02-27 CN claimed
CN-111349080-B Indole acylhydrazone compound, preparation method thereof and application of indole acylhydrazone compound in prevention and treatment of plant diseases 天津师范大学 2022-08-26 CN claimed
US-20210238204-A1 INDOLE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2021-08-05 US claimed
EP-3793976-A1 INDOLE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE THEREOF Council of Scientific & Industrial Research (IN) 2021-03-24 EP claimed
CN-111349080-A Indole acylhydrazone compound, preparation method thereof and application of indole acylhydrazone compound in prevention and treatment of plant diseases 天津师范大学 2020-06-30 CN claimed
CN-111349038-A Indolylhydrazone compounds, preparation method thereof and application thereof in preventing and treating plant diseases 天津师范大学 2020-06-30 CN claimed
CN-110973144-A Indole hydrazide-containing bactericidal composition 京博农化科技有限公司 2020-04-10 CN claimed
CN-110896956-A Indole hydrazide-containing bactericidal composition 京博农化科技有限公司 2020-03-24 CN claimed
CN-104829597-B 1H- indoles -2- carbohydrazide derivatives and its preparation method and application 厦门大学 2018-07-17 CN claimed
CN-104860866-B 5- (substitution carbon acylamino) -1H- indoles -2- carbohydrazide derivatives and its preparation method and application 厦门大学 2018-07-17 CN claimed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO claimed
CN-122059901-A 1,3, 4-Oxadiazole compound and preparation method and application thereof 成都大学 2026-05-19 CN disclosed
US-12479805-B2 Indazole hydrazide compound and application thereof BEIJING BAHEAL CHENGCHUANG PHARMACEUTICAL RESEARCH AND DEVELOPMENT CO., LTD. (CN) 2025-11-25 US disclosed
US-12479805-B2 Indazole hydrazide compound and application thereof BEIJING BAHEAL CHENGCHUANG PHARMACEUTICAL RESEARCH AND DEVELOPMENT CO., LTD. (CN) 2025-11-25 US disclosed
US-6323228-B1 INHIBITING ANGIOGENESIS IN A MAMMAL IN RECOGNIZED NEED OF SUCH TREATMENT COMPRISING ADMINISTERING TO THE MAMMAL WITH INDOLE SUBSTITUTED WITH HYDRAZIDES ABBOTT LABORATORIES 2001-11-27 US disclosed
US-6271247-B1 BINDING TO NEUROPEPTIDE RECEPTORS ADIR ET COMPAGNIE (FR) 2001-08-07 US disclosed
US-6172108-B1 NEUROPEPTIDE Y RECEPTOR LIGANDS; TREATING PSYCHOLOGICAL, EATING, SLEEP, AND SEXUAL DISORDERS; HYPOTENSIVE, ANXIOLYTIC, ANTIDEPRESSANT, AND ANTIDIABETIC AGENTS ADIR ET COMPAGNIE (FR) 2001-01-09 US disclosed
EP-1010691-A2 Hydrazide derivatives, process for their preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 2000-06-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238204-A1 INDOLE COMPOUNDS, PROCESS FOR THE PREPARATION AND USE THEREOF IDO1, IDO2, INMT KDM4E 1740/4885ALDH1A1 1363/4885GAA 1895/4885
US-12479805-B2 Indazole hydrazide compound and application thereof ITGB3, AR, HDAC3 KDM4E 755/4885ALDH1A1 306/4885GAA 3704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.